Adoption of the Uri semi-automated urine analysis system from Mast has reduced turnaround times and increased staff productivity in microbiology, as Chris Baker explains.
Northampton General Hospital pathology’s commitment to continuous improvement led to the adoption of the Mast Uri System in late 2011. The principles of Lean working practices are well embedded into the culture of the directorate, since their introduction in 2008. The microbiology department has benefited from this by streamlining its processes and using appropriate technology and automation to complement the Lean protocols. In line with this approach, the head of pathology, Gus Lusack, with the support of the clinical director, Dr Minas Minassian, introduced the Mast Uri System to the microbiology department. This system has been a great success, achieved by a combination of sound technology, dedicated and fully engaged staff, clinical engagement and implementation of Lean methods.
Prior to the arrival of the Mast Uri System, it would take approximately 48 hours to report a positive result with full sensitivities. These specimens would be identified through overnight culture on chromogenic urinary tract infection (CUTI) agar, followed up by British Society for Antimicrobial Chemotherapy (BSAC) disk susceptibility testing.
After 48 hours, results for approximately 95% of specimens were reported. Further testing was performed on isolates presenting resistance patterns or to identify Staphylococcus aureus and Pseudomonas aeruginosa. Around 5% of all samples would require further antibiotic susceptibility testing, increasing the time to result for these specimens to 72 hours.
Log in or register FREE to read the rest
This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text.
If you don't already have an account, please register with us completely free of charge.